FDA clears Medtronic’s catheter for use in the peripheral vascular system

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

The FDA cleared the TrailBlazer angled support catheter on Sept. 23 for use in the peripheral vascular system.

The catheter, which is manufactured by Medtronic, supports a guide wire during access to the peripheral arties and delivers solutions and diagnostic agents.

The TrailBlazer will be used in endovascular procedures treating complex peripheral artery disease, according to a company news release. The catheter features a stainless steel shaft and a 25- and 30-degree angled tip.